Skip to content

Managing Type 2 Diabetes Naturally An Ayurvedic Comparison

Efficay And Safety Of Trikatwadi Guggulu And Nyagrodhadi Churna In The Management Of Prameha(Type 2 Diabetes Mellitus a randomised comparative clinical trial - nill

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/04/107638
Enrollment
60
Registered
2026-04-06
Start date
Unknown
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E119- Type 2 diabetes mellitus without complications

Interventions

None listed

Sponsors

Avinash Mudgure
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patient of either gender between the age group 30 to 60 years of age.Known case of type 2 DM showing symptoms of prameha. Patients with FBS more than 125mg/dl up to 250mg/dl and PP2BS more than 200mg/dl up to 300mg/dl. Patients with HBA1c level between 7.0 mg% to 10 mg%

Exclusion criteria

Exclusion criteria: Patients having FBS more than 250mg/dl. PP2BS more than 300mg/dl and HBA1c more than 10 mg%. Patients showing acute complications and chronic complications. Neuropathy, Nephropathy,retinopathy. Patients with type 1 DM or LADA Lactating and pregnant woman Known case of acute infective diseases

Design outcomes

Primary

MeasureTime frame
It is expected that there would be significant improvements in symptoms of prameha and blood sugar levelTimepoint: Total 90 days of treatment assessment will be done on 30th 60th and 90th day

Secondary

MeasureTime frame
1)Reduced polyuria, 2)Reduced polydipsia, 3)Reduced Nocturnal Micturition, 4)Reduced Weakness 5)Reduced polyphagiaTimepoint: Total 90 days of treatment assessment will be done on 30th 60th and 90th day

Countries

India

Contacts

Public ContactAvinash Mudgure

Pt. Shivshaktilal sharma ayurveda college

drpallavimane10@gmail.com9168009138

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: May 1, 2026